Trading Signals: CYDY Stock Price Prediction and Forecast (Tue. Jul. 21, 2020 - Tue. Feb. 14, 2023)(CytoDyn Inc. )
| CYDY latest price $6.1800 (10.16%) ($5.2400 - $6.2200) on Thu. Feb. 11, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 12.92% (three month average) | RSI | 0 | Latest Price | $6.1800(10.16%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CYDY declines -1.8% a day on average for past five trading days. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CYDY advance at 0% a week (0% probability) SMH(63%) XLU(43%) VFMO(14%) PEJ(-30%) REMX(7%) | Factors Impacting CYDY price | CYDY will decline at least -6.46% in a week (0% probabilities). XRT(7%) IDRV(-94%) IBB(-25%) IWC(-19%) IWO(-36%) | | | | | Relative Volatility | | | | Market Trend Strength | -6.46% (StdDev 12.92%) | Hourly BBV | 0 () | Intraday Trend | 11.6% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $6.04(2.32%) | 10 Day Moving Average | $5.79(6.74%) | 20 Day Moving Average | $5.52(11.96%) | To recent high | -8.4% | To recent low | 20.2% | Market Cap | $3.207b | | | | CytoDyn, Inc. is a clinical-stage biotechnology company, which engages in the development of innovative treatments for multiple therapeutic indications based on leronlimab. Its product include HIV, cancer, graft-versus-host disease (GVHD), and PCa test. The company was founded by Allen D. Allen on May 2, 2002 and is headquartered in Vancouver, WA. |